Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,831 | 258 | 99.9% |
| Education | $6.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,580 | 98 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $438.18 | 26 | $0 (2023) |
| Celgene Corporation | $388.47 | 21 | $0 (2023) |
| Janssen Biotech, Inc. | $336.71 | 18 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $244.67 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $191.99 | 2 | $0 (2022) |
| PFIZER INC. | $167.51 | 10 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $165.95 | 9 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $158.13 | 9 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $136.35 | 7 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $939.77 | 38 | Phathom Pharmaceuticals, Inc. ($244.67) |
| 2023 | $838.44 | 45 | Celgene Corporation ($322.05) |
| 2022 | $652.52 | 30 | ABBVIE INC. ($262.09) |
| 2021 | $318.62 | 14 | AbbVie Inc. ($120.03) |
| 2020 | $120.96 | 7 | AbbVie Inc. ($88.47) |
| 2019 | $806.63 | 49 | AbbVie, Inc. ($278.36) |
| 2018 | $642.94 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($181.25) |
| 2017 | $518.18 | 33 | AbbVie, Inc. ($187.68) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/15/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 10/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.68 | General |
| 09/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $20.41 | General |
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: GI COLON PREP | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,005 | 1,090 | $578,448 | $132,802 |
| 2022 | 13 | 997 | 1,068 | $587,575 | $130,807 |
| 2021 | 14 | 1,124 | 1,213 | $655,282 | $147,713 |
| 2020 | 16 | 911 | 996 | $489,748 | $113,508 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 205 | 205 | $186,314 | $43,567 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 250 | $52,250 | $23,434 | 44.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 72 | 72 | $93,600 | $13,310 | 14.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 41 | 41 | $26,076 | $7,679 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $21,514 | $7,637 | 35.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $31,803 | $7,150 | 22.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 69 | 72 | $36,900 | $6,965 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 94 | $12,653 | $6,077 | 48.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 82 | 84 | $42,336 | $5,278 | 12.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $24,720 | $3,986 | 16.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $26,013 | $3,639 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $4,470 | $2,000 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,545 | $1,206 | 34.0% |
| 43450 | Dilation of esophagus | Facility | 2023 | 21 | 21 | $5,444 | $678.93 | 12.5% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $10,810 | $193.25 | 1.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 174 | 174 | $158,140 | $36,236 | 22.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 102 | 102 | $132,600 | $19,002 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 197 | $41,173 | $17,967 | 43.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 98 | 101 | $51,763 | $9,400 | 18.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 61 | 61 | $38,800 | $8,942 | 23.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 45 | 45 | $28,620 | $8,568 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 129 | $17,365 | $8,047 | 46.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $32,134 | $5,380 | 16.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 68 | 68 | $28,982 | $4,635 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $13,186 | $4,553 | 34.5% |
About Dr. Peter Koretsky, MD
Dr. Peter Koretsky, MD is a Gastroenterology healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467556456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Koretsky, MD has received a total of $4,838 in payments from pharmaceutical and medical device companies, with $939.77 received in 2024. These payments were reported across 259 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,831).
As a Medicare-enrolled provider, Koretsky has provided services to 4,037 Medicare beneficiaries, totaling 4,367 services with total Medicare billing of $524,830. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Melbourne, FL
- Active Since 09/11/2006
- Last Updated 06/16/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1467556456
Products in Payments
- ZEPOSIA (Drug) $552.77
- XIFAXAN (Drug) $348.61
- Mavyret (Drug) $257.50
- VOQUEZNA (Drug) $244.67
- Humira (Biological) $242.01
- LINZESS (Drug) $238.57
- HUMIRA (Biological) $202.13
- XELJANZ (Drug) $167.51
- TREMFYA (Drug) $137.28
- VIBERZI (Drug) $135.33
- DUPIXENT (Biological) $133.29
- CREON (Drug) $132.50
- SKYRIZI (Biological) $126.14
- XIFAXANIBSD (Drug) $121.79
- REMICADE (Biological) $115.27
- CLENPIQ (Drug) $111.94
- OCALIVA (Drug) $111.46
- RINVOQ (Biological) $110.50
- Creon (Drug) $93.39
- STELARA (Biological) $84.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Melbourne
Andrew Schmidt, Md, MD
Gastroenterology — Payments: $9,361
Shireen Gadallah, M.d, M.D
Gastroenterology — Payments: $6,843
Charles Farrington, Md, MD
Gastroenterology — Payments: $6,331
Dr. John Turse, Md, MD
Gastroenterology — Payments: $4,870
Dr. Gita Koshy, M.d, M.D
Gastroenterology — Payments: $4,501
Ian Steele
Gastroenterology — Payments: $4,067